These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Evaluation of the leucocyte adherence inhibition assay in the diagnosis of colorectal carcinoma. Leveson SH; Woodhouse LF; Giles GR Clin Oncol; 1981 Sep; 7(3):183-91. PubMed ID: 7044636 [No Abstract] [Full Text] [Related]
43. Application of immunohistochemical methods in the diagnosis of malignant disease. Imam A; Taylor CR Cancer Invest; 1985; 3(4):339-59. PubMed ID: 3896421 [No Abstract] [Full Text] [Related]
44. Gastrointestinal cancer-associated antigen in immunoperoxidase assay. Atkinson BF; Ernst CS; Herlyn M; Steplewski Z; Sears HF; Koprowski H Cancer Res; 1982 Nov; 42(11):4820-3. PubMed ID: 6751528 [TBL] [Abstract][Full Text] [Related]
45. Sensitivity and specificity of the fecal occult blood test for colorectal neoplasia. Winawer SJ; Fleisher M Gastroenterology; 1982 May; 82(5 Pt 1):986-91. PubMed ID: 7060917 [No Abstract] [Full Text] [Related]
46. The carbohydrate antigenic determinant 19-9 (CA 19-9): a monoclonal antibody defined tumor marker. DelVillano BC; Zurawski VR Lab Res Methods Biol Med; 1983; 8():269-82. PubMed ID: 6196588 [No Abstract] [Full Text] [Related]
47. Clinical evaluation of M43: a novel cancer-associated mucin epitope. Goodgame R; Kiefe C; Rose E; Sutton F; Brown J; Alpert E Cancer Res; 1993 Jun; 53(12):2803-9. PubMed ID: 7684947 [TBL] [Abstract][Full Text] [Related]
48. Symposium on the diagnosis and treatment of common cancers. 3. Colorectal carcinoma. Cummings BJ Can J Surg; 1983 May; 26(3):271-4. PubMed ID: 6850441 [TBL] [Abstract][Full Text] [Related]
49. Which method for colorectal cancer screening? Hughes WB Postgrad Med; 1999 Oct; 106(5):27-8. PubMed ID: 10560464 [No Abstract] [Full Text] [Related]
50. [Basic studies and the reference values of cancer associated antigen CA-50]. Yoshioka H; Shitara M; Sakurabayashi I; Kawai T; Suzuki M Rinsho Byori; 1988 Feb; 36(2):171-6. PubMed ID: 3288785 [No Abstract] [Full Text] [Related]
51. Improved community colorectal cancer control, Kauai. Sutherland NG; Miller R; Hall TC Hawaii Med J; 1983 Aug; 42(8):200-6. PubMed ID: 6629761 [No Abstract] [Full Text] [Related]
52. Immunohistochemical staining of colorectal tissues with monoclonal antibodies to ras oncogene p21 product and carbohydrate determinant antigen 19-9. Allen DC; Foster H; Orchin JC; Biggart JD J Clin Pathol; 1987 Feb; 40(2):157-62. PubMed ID: 3546394 [TBL] [Abstract][Full Text] [Related]
54. [Screening tests in large-intestinal neoplasms]. Tomecki R Pol Tyg Lek; 1984 May; 39(19):657-9. PubMed ID: 6384969 [No Abstract] [Full Text] [Related]
55. [Population screening for colon and rectum cancer using the Hemoccult test]. van Tongeren JH Ned Tijdschr Geneeskd; 1982 Oct; 126(43):1967-9. PubMed ID: 7177204 [No Abstract] [Full Text] [Related]
56. The contributions of virtual colonoscopy to laparoscopic colorectal surgery. Baca B; Selçuk D; Kilic IE; Erdamar S; Salihoğlu Z; Hamzaoğlu I; Karahasanoğlu T Hepatogastroenterology; 2007; 54(79):1976-82. PubMed ID: 18251142 [TBL] [Abstract][Full Text] [Related]
57. [Immunoreactivity in colorectal cancer. Approaches for an immunologic diagnosis?]. Muhrer KH; Kahle M; Pasurka B Schweiz Med Wochenschr; 1983 Apr; 113(15):546-7. PubMed ID: 6857208 [TBL] [Abstract][Full Text] [Related]
60. Application of a subcellular membrane-antibody binding assay for the analysis of antigen expression in human tumours. Price MR; Edwards S; Baldwin RW J Cancer Res Clin Oncol; 1986; 111(2):169-72. PubMed ID: 3700463 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]